Netherton Syndrome LEKTI Microbe Patent - Azitra Inc

Tue, 21 Apr 2026 13:30:11 +0000
Intellectual Property

The USPTO granted US Patent 12606610B2 to Azitra Inc covering engineered microbes expressing recombinant LEKTI domains for the treatment of Netherton Syndrome. The patent contains 15 claims spanning compositions, methods, and kits. Inventors are Travis Michael Whitfill and Azim Momin Munivar.